Omid Mirmosayyeb1, Mahdi Barzegar2, Nasim Nehzat1, Vahid Shaygannejad2, Mohammad Ali Sahraian3, Mahsa Ghajarzadeh4. 1. Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran; Universal Council of Epidemiology (UCE), Universal Scientific Education and Research Network (USERN), Tehran University of Medical Sciences, Tehran, Iran. 2. Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran; Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran. 3. Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran. 4. Universal Council of Epidemiology (UCE), Universal Scientific Education and Research Network (USERN), Tehran University of Medical Sciences, Tehran, Iran. Electronic address: m-ghajarzadeh@farabi.tums.ac.ir.
Abstract
OBJECTIVES: We designed this systematic review to estimate pooled prevalence of migraine in patients with multiple sclerosis (MS). METHODS: We searched PubMed, Scopus, EMBASE, CINAHL, Web of Science, google scholar and gray literature including references from identified studies, conference abstracts which were published up to December 2019. The search strategy included the MeSH and text words as ((Disorder,Migraine OR Disorders,MigraineDisorder OR Migraine OR Migraines, OR MigraineHeadache OR MigraineHeadaches) AND (Multiple Sclerosis OR Sclerosis, Multiple) OR Sclerosis, Disseminated) OR Disseminated Sclerosis) OR MS (Multiple Sclerosis)) OR Multiple Sclerosis, Acute Fulminating). RESULTS: The literature search found 2100 articles. After eliminating duplicates, 1500 articles remained. Eleven articles and twelve abstract conference papers were included for final analysis. A total of 11,372 MS cases and 2627 MS patients with migraine included in the analysis. The prevalence of migraine ranged from 2% to 67%. The pooled prevalence of migraine in included studies was 31% (95%CI: 22%-40%) (I2 = 99.3%, p < 0.001). The pooled prevalence of migraine in different continents were significantly different (p < 0.001). The pooled prevalence was 24% in Asian countries, 43% in American countries, 25% in European countries and 43% in African countries. CONCLUSION: The results of this systematic review shows that the prevalence of migraine in MS patients is 31% while the prevalence differs significantly among residents of different continents.
OBJECTIVES: We designed this systematic review to estimate pooled prevalence of migraine in patients with multiple sclerosis (MS). METHODS: We searched PubMed, Scopus, EMBASE, CINAHL, Web of Science, google scholar and gray literature including references from identified studies, conference abstracts which were published up to December 2019. The search strategy included the MeSH and text words as ((Disorder,Migraine OR Disorders,MigraineDisorder OR Migraine OR Migraines, OR MigraineHeadache OR MigraineHeadaches) AND (Multiple Sclerosis OR Sclerosis, Multiple) OR Sclerosis, Disseminated) OR Disseminated Sclerosis) OR MS (Multiple Sclerosis)) OR Multiple Sclerosis, Acute Fulminating). RESULTS: The literature search found 2100 articles. After eliminating duplicates, 1500 articles remained. Eleven articles and twelve abstract conference papers were included for final analysis. A total of 11,372 MS cases and 2627 MS patients with migraine included in the analysis. The prevalence of migraine ranged from 2% to 67%. The pooled prevalence of migraine in included studies was 31% (95%CI: 22%-40%) (I2 = 99.3%, p < 0.001). The pooled prevalence of migraine in different continents were significantly different (p < 0.001). The pooled prevalence was 24% in Asian countries, 43% in American countries, 25% in European countries and 43% in African countries. CONCLUSION: The results of this systematic review shows that the prevalence of migraine in MS patients is 31% while the prevalence differs significantly among residents of different continents.
Authors: Samantha Epstein; Zongqi Xia; Annie J Lee; Megan Dahl; Keith Edwards; Elle Levit; Erin E Longbrake; Christopher Perrone; Katelyn Kavak; Bianca Weinstock-Guttman; Fatoumata Diallo; Adelle Ricci; Claire S Riley; Philip L De Jager; Rebecca Farber; Sarah F Wesley Journal: Mult Scler Relat Disord Date: 2021-12-02 Impact factor: 4.339